EDVANYSEBeveragesFiscal year ends December 31
Endovia Health Sciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.14−0.01 (-7.53%)
Close on Oct 19, 2026
- Market cap
- $413.76K
- P/E (TTM)
- –
- Dividend yield
- –
Endovia Health Sciences, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| E Commerce [Member] | $59.01K | $646.15K | $13.78M | $6.86M | $1.90M | – | 80.8% | -90.9% |
| Splash Beverage Group [Member] | $14.05K | $155.12K | $5.07M | $4.46M | $404.13K | $20.39K | 19.2% | -90.9% |
| Medical Devices Discontinued [Member] | – | – | – | – | $675.21K | – | – | – |
By region
From the segment and revenue-disaggregation notes of Endovia Health Sciences's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.